HomeCUE • NASDAQ
add
Cue Biopharma Inc
Previous close
$1.03
Day range
$1.01 - $1.08
Year range
$0.45 - $3.25
Market cap
61.41M USD
Avg Volume
806.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.34M | 58.86% |
Operating expense | 3.77M | 3.35% |
Net income | -8.66M | 21.31% |
Net profit margin | -259.59 | 50.46% |
Earnings per share | -0.17 | 28.77% |
EBITDA | -8.81M | 21.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.42M | -40.72% |
Total assets | 44.81M | -34.95% |
Total liabilities | 19.44M | -25.85% |
Total equity | 25.37M | — |
Shares outstanding | 63.35M | — |
Price to book | 2.45 | — |
Return on assets | -51.14% | — |
Return on capital | -65.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.66M | 21.31% |
Cash from operations | -7.53M | 3.49% |
Cash from investing | 98.00K | -98.04% |
Cash from financing | 9.82M | 114.01% |
Net change in cash | 2.39M | 33.63% |
Free cash flow | -5.98M | -10.12% |
About
Founded
2014
Headquarters
Website
Employees
53
